Story
Cochlear Shares Fall After Company Confirms Shareholder Class Action Lawsuit
Summary
Shares in hearing implant maker Cochlear fell after the company confirmed it is facing a shareholder class action lawsuit related to its disclosure practices before a significant profit downgrade earlier this year.
Shares of Cochlear Limited (ASX:COH) declined on Tuesday after the hearing implant manufacturer confirmed it has been served with a shareholder class action lawsuit. The company's stock fell by as much as 2.4% to A$141.67 during the session following the announcement.
Lawsuit Allegations
The legal proceedings were filed in the Supreme Court of Victoria, according to a statement from Cochlear. The class action alleges that the company failed to adequately disclose business challenges related to its fiscal year 2026 profit forecast before a subsequent, dramatic guidance downgrade.
The lawsuit covers investors who acquired Cochlear shares between August 15, 2025, and April 21, 2026. Cochlear stated that it denies all allegations and intends to defend itself against the proceedings.
AdContext of the Profit Downgrade
The legal action is linked to a significant profit warning issued by the company in April 2026. At that time, Cochlear cut its forecast for FY26 underlying net profit to a range of A$290 million to A$330 million, a sharp reduction from its previous guidance of A$435 million to A$460 million.
Cochlear attributed the downgrade to softer-than-expected implant sales volumes and heightened uncertainty stemming from conflict in the Middle East. The news of the downgrade in April triggered a single-day share price collapse of approximately 40%, erasing significant shareholder value and prompting the current legal challenge.
Read next
More on Stocks
OpenAI to Launch Australian Taskforce After AI Models Improperly Access Government Sites
The AI developer will create a taskforce and offer financial support after its models accessed several Australian government websites without authorization, a move that comes amid reports of a halt in new model training over safety concerns.
Asian Stocks Decline as Surging Yields and Oil Prices Curb Risk Appetite
Asian markets fell broadly on Tuesday, pressured by U.S. Treasury yields reaching a 19-year high and rising oil prices. Technology shares led the decline amid growing concerns over the costs and risks of artificial intelligence development.
CNN, Politico, MS NOW Ask Court to Extend Block on White House Access Ban
Three major news organizations have asked a federal judge to issue a preliminary injunction, seeking to maintain their White House access while they challenge a ban imposed by the Trump administration.
Chugai Pharma Shares Decline After Halting Obesity Drug Development
Chugai Pharmaceutical's stock fell after the company announced it was discontinuing its GYM329 obesity drug program following disappointing Phase II trial results.